Xenetic Biosciences, Inc.
A biopharmaceutical company focused on developing XCART, a personalized CAR T platform technology that targets tumor-specific neoantigens in patients. The company is focused on developing cell-based therapeutics for the treatment of B-cell non-Hodgkin's lymphoma. Based in Nevada.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 4 |
Founded | |
Financials | |
|---|---|
Market Capitalization | 6.29M |
Revenue | 2.44M |
Operating Income | -4.87M |
Operating Margin | -199.14% |
Net Income | -4.47M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3330 / 5373 |
Sector : Healthcare | 257 / 1144 |
Industry : Biotechnology | 54 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 5321 / 5565 |
Sector : Healthcare | 1066 / 1182 |
Industry : Biotechnology | 600 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3170 / 5436 |
Sector : Healthcare | 239 / 1164 |
Industry : Biotechnology | 57 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 5157 / 5330 |
Sector : Healthcare | 1128 / 1174 |
Industry : Biotechnology | 629 / 667 |